DOSEN PROFIL LENGKAP

	; Archives (Index) ;
	2012; 2016; 2017; 2018;
	This page is archived by ClueBot III.

This article is rated B-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals
Low	This article has been rated as Low-importance on the project's importance scale.

Companies High‑importance

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany

High This article has been rated as High-importance on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

Germany Mid‑importance

	Germany portal This article is within the scope of WikiProject Germany, a collaborative effort to improve the coverage of Germany on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.GermanyWikipedia:WikiProject GermanyTemplate:WikiProject GermanyGermany
Mid	This article has been rated as Mid-importance on the project's importance scale.

Pharmacology High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
High	This article has been rated as High-importance on the project's importance scale.

The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.

Heinrich-Emanuel (talk · contribs) has been paid by Merck KGaA.

Precision Farming

"Merck got into cow collars in 2019 when it bought Allflex, a company that makes them, betting that the animal health industry would grow. Merck sells the collars and software for a monthly subscription of around $3 a cow and monitors over two million cows, or 20 percent of the U.S. herd. The company also sells ear tags that light up blue to show farmers which cows to tend to."(NewYorktimes, 2025)

https://www.nytimes.com/2025/10/05/technology/cows-ai-collars.html?smid=nytcore-ios-share&referringSource=articleShare SeriousLeeFiction (talk) 14:46, 5 October 2025 (UTC)[reply]

Suggestion to update management and financials

This edit request by an editor with a conflict of interest has now been answered.

Dear all,

I would like to suggest to update the key people section as well as the financials in the infobox. Please note that I have a financial conflict of interest as I am an employee of Merck Group.

Suggested changes to the Infobox

CEO

1. Please remove the current CEO in the key people section:

Belén Garijo (CEO and chairman of the executive board)

2. Please add the Kai Beckmann as CEO to the key people section:

Kai Beckmann (CEO and chairman of the executive board)

3. Using as the reference:

Smolak, Helena (2025-09-25). "Kai Beckmann wird Nachfolger von Belén Garijo bei Merck". Handelsblatt (in German). Retrieved 2026-05-06.

4. Reason for change being made:

Change of CEO effective 1 May 2026.

Revenue

1. Please remove the current revenue in the infobox:

€21.16 billion (2024)

2. Please add the following as revenue to the infobox:

€21.10 billion (2025)

3. Using as the reference:

"Annual Report 2025" (PDF). Merck KGaA. p. 2. Retrieved 2026-05-06.

4. Reason for change being made:

Revenue for fiscal year 2025.

Operating Income

1. Please remove the current operating income in the infobox:

€3.645 billion (2024)

2. Please add the following as operating income to the infobox:

€3.601 billion (2025)

3. Using as the reference:

"Annual Report 2025" (PDF). Merck KGaA. p. 2. Retrieved 2026-05-06.

4. Reason for change being made:

Operating income for fiscal year 2025.

Net Income

1. Please remove the current net income in the infobox:

€2.777 billion (2024)

2. Please add the following as net income to the infobox:

€2.615 billion (2025)

3. Using as the reference:

"Annual Report 2025" (PDF). Merck KGaA. p. 2. Retrieved 2026-05-06.

4. Reason for change being made:

Net income for fiscal year 2025.

Assets

1. Please remove the current assets in the infobox:

€51.57 billion (2024)

2. Please add the following as assets to the infobox:

€51.53 billion (2025)

3. Using as the reference:

"Annual Report 2025" (PDF). Merck KGaA. p. 64. Retrieved 2026-05-06.

4. Reason for change being made:

Assets for fiscal year 2025.

Equity

1. Please remove the current equity in the infobox:

€29.99 billion (2024)

2. Please add the following as equity to the infobox:

€28.66 billion (2025)

3. Using as the reference:

"Annual Report 2025" (PDF). Merck KGaA. p. 64. Retrieved 2026-05-06.

4. Reason for change being made:

Equity for fiscal year 2025.

Employees

1. Please remove the current number of employees in the infobox:

62,557 (2024)

2. Please add the following as number of employees to the infobox:

62,461 (2025)

3. Using as the reference:

"Annual Report 2025" (PDF). Merck KGaA. p. 3. Retrieved 2026-05-06.

4. Reason for change being made:

Number of employees as of 31 december 2025.

I am looking forward to feedback from independent editors. Greatly appreciate everybody’s time for this! Best, Heinrich-Emanuel (talk) 08:20, 6 May 2026 (UTC)[reply]

Done. Infobox updates are not critical. Grimes 2 17:39, 6 May 2026 (UTC)[reply]

@Grimes2: I've closed the request. Feel free to reopen it if you want, but please remember to close requests (see the template's docs) when you're done, it is especially important when the queue is so long. Seercat3160 (talk) 07:49, 10 May 2026 (UTC)[reply]

Suggestion for update

The user below has a request that an edit be made to Merck Group. That user has an actual or apparent conflict of interest.
The requested edits backlog is very high. Please be extremely patient. There are currently 567 requests waiting for review.

Please read the instructions for the parameters used by this template for accepting and declining them, and review the request below and make the edit if it is well sourced, neutral, and follows other Wikipedia guidelines and policies.

Dear all,

I would like to suggest to update one information in the article related to the brand use of Merck inside and outside the U.S. and Canada. Please note that I have a financial conflict of interest as I am an employee of Merck Group.

Introduction

1. Please remove the last two sentences of the fourth paragraph of the article:

The original Merck of Darmstadt holds the rights to the name Merck in all countries except the U.S. and Canada, where it is known as EMD (Emanuel Merck, Darmstadt), and the life science business specifically is known as MilliporeSigma. In 2015 Merck adopted a uniform brand identity for all its subsidiaries, and the company has stressed its intention to protect the brand of "the real Merck" globally and initiated litigation against its former subsidiary over use of the name.

2. Please add the following as the last two sentences of the fourth paragraph to the article:

Merck KGaA of Darmstadt holds the rights to the name Merck in all countries except the U.S. and Canada, where its businesses operate under "EMD Serono" in Healthcare, "MilliporeSigma" in Life Science and "EMD Electronics" in Electronics. Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada.

3. Using as the reference:

Burger, Ludwig (2016-01-15). "Fight over Merck name sees German firm win in British court". Reuters. Retrieved 2026-05-22.

4. Reason for change being made: Suggestion to update the two sentences after court rule in 2016.

I am looking forward to feedback from independent editors. Please also let me know if you have any questions. Greatly appreciate everybody’s time for this! Best, Heinrich-Emanuel (talk) 07:22, 22 May 2026 (UTC)[reply]

DOSEN PROFIL LENGKAP

Talk:Merck Group

Precision Farming

Suggestion to update management and financials

Suggestion for update

Content Disclaimer

Archives (Index)
2012 2016 2017 2018
This page is archived by ClueBot III.